D2C7-IT + 2141-V11 Combination Post-resection in rGBM

NCT06455605 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

46

Enrollment

OTHER

Sponsor class

Conditions

Recurrent Glioblastoma IDH Wildtype

Interventions

DRUG: D2C7-IT
DRUG: 2141 V11

Sponsor

Darell Bigner

Collaborators

[object Object]